MedTrace Logo

Antibiotic Prophylaxis - Amoxicillin

NCT01829529 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2016-09-02

No results posted yet for this study

Summary

The hypothesis of the present study is that quantitative and qualitative oral microflora alterations and changes in antibiotic susceptibility among oral commensal microflora will occur following a single dose administration of amoxicillin.

Conditions

  • Healthy

Interventions

DRUG

Amoxicillin

Amoxicillin

Sponsors & Collaborators

  • Bodil Lund

    lead OTHER

Principal Investigators

  • Margareta Hultin, Dentist · Department of Dental Medicine, Karolinska Institute

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-03-31
Completion
2016-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01829529 on ClinicalTrials.gov